Oragenics News

Oragenics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jan 8 06:09 ET

Oragenics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Dec 31 11:50 ET

Oragenics | S-1: General form for registration of securities under the Securities Act of 1933

Dec 18, 2024 10:04 ET

Oragenics | 8-K: Current report

Dec 16, 2024 16:13 ET

Oragenics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 16, 2024 16:09 ET

Oragenics | 4: Statement of changes in beneficial ownership of securities-Director KOSKI ROBERT C

Dec 13, 2024 16:08 ET

Oragenics | 4: Statement of changes in beneficial ownership of securities-Director DUNTON ALAN W

Dec 9, 2024 18:11 ET

Oragenics | 4: Statement of changes in beneficial ownership of securities-Director Telling Fred

Dec 9, 2024 16:27 ET

Oragenics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 6, 2024 16:40 ET

Oragenics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 6, 2024 14:05 ET

Oragenics | 8-K: Current report

Nov 29, 2024 17:04 ET

Oragenics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0.0%),Lind Global Partners II LLC(0.0%), etc.

Nov 14, 2024 19:33 ET

Oragenics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Iroquois Capital Management L.L.C.(0.0%),Richard Abbe(0.0%), etc.

Nov 14, 2024 16:03 ET

Oragenics | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 14:43 ET

Oragenics | DEFA14A: Others

Oct 31, 2024 09:20 ET

Oragenics | DEF 14A: Definitive information statements

Oct 31, 2024 09:15 ET

Oragenics | 8-K: Current report

Oct 18, 2024 08:34 ET

Oragenics | 8-K: Current report

Oct 16, 2024 10:32 ET

Oragenics | 8-K: Current report

Oct 15, 2024 12:44 ET

Oragenics | 424B5: Prospectus

Oct 11, 2024 16:49 ET